Wikidata

(Q54479081)

English

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.

scientific article

In more languages

Statements

title
Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23044928
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/23044928

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54479081&oldid=1725099860"